Brokerages expect Amdocs Limited (NASDAQ:DOX) to post $1.01 billion in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Amdocs’ earnings. The highest sales estimate is $1.01 billion and the lowest is $1.00 billion. Amdocs reported sales of $977.71 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 3.3%. The company is expected to report its next earnings results on Tuesday, January 29th.
According to Zacks, analysts expect that Amdocs will report full-year sales of $4.09 billion for the current fiscal year, with estimates ranging from $4.07 billion to $4.09 billion. For the next financial year, analysts forecast that the firm will post sales of $4.22 billion, with estimates ranging from $4.17 billion to $4.26 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Amdocs.
Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Thursday, November 8th. The technology company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.02). The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1 billion. Amdocs had a return on equity of 15.06% and a net margin of 8.92%. The company’s revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.94 earnings per share.
A number of equities research analysts have issued reports on the stock. Zacks Investment Research lowered shares of Amdocs from a “hold” rating to a “sell” rating in a research note on Monday, December 3rd. BidaskClub raised shares of Amdocs from a “strong sell” rating to a “sell” rating in a research note on Friday, September 14th. Finally, TheStreet lowered shares of Amdocs from a “b” rating to a “c+” rating in a research note on Friday, November 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $72.60.
Several hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace LLP lifted its stake in shares of Amdocs by 18.5% in the 3rd quarter. Marshall Wace LLP now owns 314,970 shares of the technology company’s stock valued at $20,782,000 after purchasing an additional 49,109 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Amdocs by 12.9% in the 3rd quarter. Vanguard Group Inc. now owns 906,097 shares of the technology company’s stock valued at $59,784,000 after purchasing an additional 103,299 shares during the last quarter. Morgan Stanley lifted its stake in shares of Amdocs by 49.7% in the 3rd quarter. Morgan Stanley now owns 636,564 shares of the technology company’s stock valued at $42,000,000 after purchasing an additional 211,215 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of Amdocs by 9.3% in the 3rd quarter. Legal & General Group Plc now owns 749,829 shares of the technology company’s stock valued at $49,482,000 after purchasing an additional 63,620 shares during the last quarter. Finally, Standard Life Aberdeen plc lifted its stake in shares of Amdocs by 6.1% in the 3rd quarter. Standard Life Aberdeen plc now owns 3,070,343 shares of the technology company’s stock valued at $202,627,000 after purchasing an additional 176,096 shares during the last quarter. 91.15% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ:DOX opened at $60.29 on Friday. The firm has a market cap of $9.15 billion, a price-to-earnings ratio of 16.12, a P/E/G ratio of 1.92 and a beta of 0.51. Amdocs has a 12-month low of $60.28 and a 12-month high of $71.72.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 18th. Shareholders of record on Monday, December 31st will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date of this dividend is Friday, December 28th. Amdocs’s dividend payout ratio (DPR) is currently 26.74%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.
Further Reading: The Role of a Fiduciary and Individual Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.